Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

Revenues for LALPATHLAB are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 3.47600
forwardPE 38.83000
debtToEquity 7.83100
earningsGrowth -0.15400
revenueGrowth 0.20600
grossMargins 0.63763
operatingMargins 0.22871
trailingEps 31.58000
forwardEps 35.38501

LALPATHLAB's current ratio of 3.476 highlights the company's ability to easily cover its short-term debt using its available cash and assets. This indicates a strong liquidity position, ensuring LALPATHLAB is unlikely to face difficulties in meeting immediate financial obligations.
Dr. Lal PathLabs Limited's low growth in both earnings and revenue signals a potential profit decline. This could be a sign of financial trouble, suggesting that the company's profitability might shrink in the near future.
LALPATHLAB's positive gross and operating margins reflect strong financial performance. These metrics indicate that the company is efficiently managing its operations and generating healthy profits, contributing to a solid financial position.
LALPATHLAB's forward EPS being higher than its trailing EPS points to expected growth in profitability. This suggests that the company is projected to perform better in the current financial year, with higher earnings forecasted compared to the previous year.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

LALPATHLAB's price has consistently hovered around the lower end of analysts' projections. This pattern may reflect concerns regarding the company's ability to achieve its anticipated growth.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


Dr. Lal PathLabs Limited experienced 38 selling transactions, with market price of 2955.796046206826.1 LALPATHLAB stock purchases took place, with market price of 3308.5.Insider transactions show no strong upward or downward movement, offering little insight into the company's future performance or strategic direction.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


LALPATHLAB has been receiving a buy bias from analysts, signaling strong confidence in the stock's future performance. This positive outlook might drive investors to view LALPATHLAB as an attractive option for their portfolios, positioning the company as a stable and profitable investment choice.